B LYMPHOBLASTIC LYMPHOMA
Clinical trials for B LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new B LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for B LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to beat tough childhood leukemia
Disease control Recruiting nowThis phase 3 trial tests whether adding the targeted drug inotuzumab ozogamicin to standard chemotherapy and immunotherapy improves outcomes for children and young adults with high-risk B-cell acute lymphoblastic leukemia (B-ALL). The study will enroll about 6,000 participants an…
Matched conditions: B LYMPHOBLASTIC LYMPHOMA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Promising combo therapy aims to beat B-ALL without transplant
Disease control Recruiting nowThis phase II trial is testing whether adding two immunotherapy drugs (blinatumomab and inotuzumab ozogamicin) to a standard chemotherapy regimen (Hyper-CVAD) can improve outcomes for adults newly diagnosed with B-cell acute lymphoblastic leukemia (B-ALL). The study plans to enro…
Matched conditions: B LYMPHOBLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Can we safely use less blood for leukemia patients?
Knowledge-focused Recruiting nowThis study looks at whether giving blood transfusions only when hemoglobin drops below 7 gm/dL (instead of 9 gm/dL) is safe and maintains quality of life in leukemia patients after chemotherapy or stem cell transplant. About 50 adults with certain blood cancers will be randomly a…
Matched conditions: B LYMPHOBLASTIC LYMPHOMA
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC